Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$4.84 - $9.07 $968,000 - $1.81 Million
-200,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.21 - $14.28 $120,401 - $408,393
28,599 Added 16.69%
200,000 $1.25 Million
Q3 2018

Nov 14, 2018

BUY
$13.02 - $17.54 $2.07 Million - $2.79 Million
158,901 Added 1271.21%
171,401 $2.4 Million
Q2 2018

Aug 14, 2018

BUY
$16.51 - $19.85 $206,375 - $248,125
12,500 New
12,500 $206,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $779M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.